Komori
Other Disclosures4912Lion CorporationMaterials and Chemicals

Notice Regarding an Investment in a U.S. Venture Capital Fund Specializing in Oral Healthcare Startup Investments

Lion Corporation entered into an agreement to invest in a venture capital fund that invests in U.S. startups involved in oral healthcare. Through this investment, the Company aims to pursue co-creation with startups and create new business opportunities in Asia.

Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
100000000
U.S. dollars (fund size)
Wording
Conditional
How definitive the wording is.

Announced details

Oral healthcare (OHC) business
Applicable field (uses covered by this announcement)

Oral health, dentistry, oral hygiene, oral function (the ability to chew, swallow and enjoy conversation), and healthcare technology

Contract Date6 August 2026
Relationship between the counterparty and the company
Lion Corporation4912
Relationship with the Company

Lion Corporation entered into an agreement to invest in a fund formed by Revere. Other capital, personnel and business relationships: Not disclosed.

CounterpartyRevere Partners RF, LLC

Based in New York State, United States. Representative: Jeremy Krell. A venture capital firm specializing in dentistry and oral healthcare. Established in 2021. The firm has a network that includes dental associations, dental clinics, dental insurers, dental materials and equipment manufacturers, and dental distributors.

Location (as indicated in this announcement)

New York State, United States (Revere)

The fund has commitments of $100 million. Its investment period is 10 years, with the possibility of an extension of up to 2 years.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredOral healthcare (OHC) business
CounterpartyRevere Partners RF, LLC
Counterparty overviewBased in New York State, United States. Representative: Jeremy Krell. A venture capital firm specializing in dentistry and oral healthcare. Established in 2021. The firm has a network that includes dental associations, dental clinics, dental insurers, dental materials and equipment manufacturers, and dental distributors.
Relationship with the CompanyLion Corporation entered into an agreement to invest in a fund formed by Revere. Other capital, personnel and business relationships: Not disclosed.
Contract Date6 August 2026
Applicable areaOral health, dentistry, oral hygiene, oral function (the ability to chew, swallow and enjoy conversation), and healthcare technology
LocationNew York State, United States (Revere)
Location scaleThe fund has commitments of $100 million. Its investment period is 10 years, with the possibility of an extension of up to 2 years.
Items this document does not state (10)
Contract ValueOffering priceLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To expand the oral healthcare business, the Company’s highest-priority business, as part of efforts to strengthen earning power, a key theme of its medium-term management plan. The Company aims to accelerate and deepen co-creation with startups and use the knowledge gained in Asia to create new business opportunities.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding an Investment in a U.S. Venture Capital Fund Specializing in Oral Healthcare Startup Investments | Lion Corporation (4912) timely disclosure | Komori